Cathie Wood’s ARK sells Alphabet stock, buys Rocket Lab
ARK ETFs sold 16,422 Alphabet (GOOGL) shares for $5.8M, bought 359,612 Rocket Lab (RKLB) shares for $25.1M. Also reduced Twist Bioscience (TWST) and 10X Genomics (TXG) positions, while increasing stakes in Scribe Therapeutics (SCTX), Veracyte (VCYT), and Beam Therapeutics (BEAM).
How this was made
The 30-second read
Why it matters
The trades suggest a strategic pivot toward space and biotech, possibly anticipating sector tailwinds.
Market read
Fund activity can move small- to mid-cap stocks; ARK's sizable purchases may influence price dynamics.
What to watch
Potential upcoming regulatory scrutiny on big tech could be driving the Alphabet sell.
Background
ARK's daily trade disclosures provide insight into its evolving portfolio allocations.
Ticker impact
ARK purchased 359,612 shares of Rocket Lab, a $25.1M investment, indicating increased exposure.
moderate upside pressure
Large fund buy suggests confidence in growth prospects.
ARK sold 16,422 shares of Alphabet, a $5.8M divestiture, reducing exposure.
slight downside risk
Sell size modest relative to market cap.
ARK sold 21,335 shares of Twist Bioscience, a $3.5M reduction.
minimal effect
Sell amount small relative to float.
ARK sold 49,651 shares of 10X Genomics, a $3.9M divestiture.
minimal impact
Sell size modest.
ARK bought 88,323 shares of Scribe Therapeutics, a $2.5M investment.
potential upside
Fund accumulation indicates confidence.
ARK bought 12,583 shares of Veracyte, a $0.5M purchase.
slight upside
Purchase size relatively small.
ARK bought 9,519 shares of Beam Therapeutics, a $0.24M purchase.
limited upside
Very small trade size.
ARK sold 19,139 shares of Everpure, a $2.2M divestiture.
minimal effect
Trade size modest relative to market.
Market effects
Increased focus on space launch and biotech sectors from ARK's reallocation.
US market exposure shifts modestly toward growth-oriented biotech and aerospace firms.
Limited global impact; primarily influences US-listed growth stocks.
Counterpoint
ARK's reduction in Alphabet may signal overvaluation concerns despite broader tech strength.
Key entities
- PersonCathie Wood
Founder of ARK Invest, guiding fund strategy.
- FirmARK Invest
Active manager of thematic ETFs.
